Evidence map›Paper›PMID 19563773›Full record

ArticleArchives of biochemistry and biophysics2009

Inhibition of human folylpolyglutamate synthetase by diastereomeric phosphinic acid mimics of the tetrahedral intermediate.

John J McGuire, David M Bartley, John W Tomsho, William H Haile, James K Coward

Erratum issuedAbstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

John J McGuireGrace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. John.McGuire@RoswellPark.edu
David M Bartley
John W Tomsho
William H Haile
James K Coward
University of Michigan–Ann Arbor · USGrace (United States) · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
INTERDEPARTMENTAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007767 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ISOM, LORI L. · 1985 to 2019
$10.2M
MICHIGAN CHEMISTRY-BIOLOGY INTERFACE TRAINING PROGRAMT32GM008597 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTGOMERY, JOHN · 1996 to 2018
$5.0M
RATIONAL DRUG DESIGN BASED ON CHEMICAL MECHANISMSR01CA028097 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COWARD, JAMES K · 1985 to 2005
$1.6M
HUMAN LEUKEMIA FOLYPOLYGLUTAMATE SYNTHETASE INHIBITORSR01CA043500 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MCGUIRE, JOHN J · 1986 to 2003
$726k
NCI NIH HHS CA16056NCI NIH HHS CA28097NCI NIH HHS CA43500NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA028097NCI NIH HHS R01 CA043500NIGMS NIH HHS GM007767NIGMS NIH HHS GM008597NIGMS NIH HHS T32 GM007767NIGMS NIH HHS T32 GM008597
6 · The paper itself

Abstract

Phosphorus-containing pseudopeptides, racemic at the C-terminal alpha-carbon, are potent mechanism-based inhibitors of folylpolyglutamate synthetase (FPGS). They are mimics of the tetrahedral intermediate postulated to form during FPGS-catalyzed biosynthesis of poly(gamma-l-glutamates). In the present paper, the FPGS inhibitory activity of each diastereomer coupled to three heterocycles is reported. The high R(f) pseudopeptide containing the 5,10-dideazatetrahydropteroyl (DDAH(4)Pte) heterocycle is most potent (K(is) = 1.7 nM). While the heterocyclic portion affects absolute FPGS inhibitory potency, the high R(f) species is more potent in each pair containing the same heterocycle. This species presumably has the same stereochemistry as the natural folate polyglutamate, i.e., (l-Glu-gamma-l-Glu). Unexpectedly, the low R(f) (presumed l-Glu-gamma-d-Glu) species are only slightly less potent (<30-fold) than their diastereomers. Further study of this phenomenon comparing l-Glu-gamma-l-Glu and l-Glu-gamma-d-Glu dipeptide-containing FPGS substrates shows that <1% contamination of commercial d-Glu precursors by l-Glu may give misleading information if l-Glu-gamma-l-Glu substrates have low K(m) values.

Indexed as

CytosolFolic Acidgamma-Glutamyl HydrolaseGlutamate Carboxypeptidase IIGlutamatesHumansInhibitory Concentration 50KineticsMolecular StructurePeptide SynthasesPhosphinic AcidsPseudomonasRecombinant ProteinsSolubilityStereoisomerismStructure-Activity RelationshipFolic Acidfolylpolyglutamate synthetasegamma-Glutamyl HydrolaseGlutamate Carboxypeptidase IIGlutamatesPeptide SynthasesPhosphinic AcidsRecombinant Proteins

Identifiers

PMID19563773
PMCPMC2757737
OpenAlexW2040928600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.